Lobos Urbina Diego, Peña Durán José
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile. Address: Facultad de Medicina, Pontificia Universidad Católica de Chile, Lira 63, Santiago Centro, Chile. Email:
Proyecto Epistemonikos, Santiago, Chile; Departamento Hemato-Oncología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Cáncer Nuestra Señora de la Esperanza, Red de Salud UC-Christus, Santiago, Chile.
Medwave. 2016 Sep 14;16 Suppl 3:e6539. doi: 10.5867/medwave.2016.6539.
Cannabinoids have been proposed for the treatment of patients with cancer pain, especially if standard treatment does not control symptoms. Using Epistemonikos database, which is maintained by searching 30 databases, we identified nine systematic reviews including seven trials that answer the question of interest, of which six are randomized trials. We performed a meta-analysis and generated a summary of findings table using the GRADE approach. We concluded it is unclear whether cannabinoids decrease pain and improve quality of life in patients with refractory cancer pain because the certainty of the evidence is very low, and it probably increases adverse effects substantially.
大麻素已被提议用于治疗癌症疼痛患者,尤其是在标准治疗无法控制症状的情况下。通过搜索30个数据库维护的Epistemonikos数据库,我们确定了9项系统评价,其中包括7项回答感兴趣问题的试验,其中6项为随机试验。我们进行了荟萃分析,并使用GRADE方法生成了结果总结表。我们得出结论,尚不清楚大麻素是否能减轻难治性癌症疼痛患者的疼痛并改善其生活质量,因为证据的确定性非常低,而且它可能会大幅增加不良反应。